| Januase Kinase Inhibitor Baricitinib is not an ideal option for management of COVID - 19 D Praveen, PR Chowdary, MV Aanandhi International Journal of Antimicrobial Agents 55 (5), 105967-105967, 2020 | 112* | 2020 |
| Synthesis and antimicrobial activities of 1-(5-substituted-2-oxo indolin-3-ylidene)-4-(substituted pyridin-2-yl) thiosemicarbazide V Aanandhi, S George, V Vaidhyalingam Arkivoc 11, 187-194, 2008 | 45 | 2008 |
| Synthesis and characterization of novel mannich bases of benzimidazole derivatives for antibacterial and antifungal activity MV Aanandhi, AK Verma, R Sujatha, RK Raj International Journal of Pharmacy and Pharmaceutical Sciences 5 (2), 295-297, 2013 | 28 | 2013 |
| Simultaneous estimation of amoxicillin and flucloxacillin in its combined capsule dosage form by HPLC P Shanmugasundaram, RK Raj, J Mohanrangan, G Devdass, ... Rasayan J chem 2 (1), 57-60, 2009 | 27 | 2009 |
| A review on role of Vitamin E supplementation in type 2 diabetes mellitus D Pavithra, D Praveen, PR Chowdary, MV Aanandhi Drug Invent. Today 10 (2), 236-240, 2018 | 26 | 2018 |
| Synthesis and pharmacological evaluation of 1-(1-((substituted) methyl)-5-methyl-2-oxoindolin-3-ylidene)-4-(substituted pyridin-2-yl) thiosemicarbazide VA Muthukumar, S George, V Vaidhyalingam Biological and Pharmaceutical Bulletin 31 (7), 1461-1464, 2008 | 25 | 2008 |
| Quantitative estimation of piperine in herbal cough syrup by HPTLC method P Shanmugasundaram, R Maheswari, M Vijayaanandhi Rasayan Journal of Chemistry 1 (2), 212-7, 2008 | 25 | 2008 |
| Synthesis and anticonvulsant activity of thiazolidinone derivatives S Shanmuga Priya, V Aanandhi Synthesis 4 (1), 01-04, 2012 | 24 | 2012 |
| A Prospective Study on Incidence of Dyslipidemia in Diabetes Mellitus VAM Ranadheer Chowdary P, Praveen. D Research J. Pharm. and Tech. 10 (2), 431-433, 2017 | 22 | 2017 |
| Association of vitamin C status in diabetes mellitus: Prevalence and predictors of vitamin C deficiency D Praveen, RC Puvvada, V Aanandhi Future Journal of Pharmaceutical Sciences 6 (30), 1-5, 2020 | 21 | 2020 |
| Synthesis and biological evaluation of Pyrido(2,3-d)pyrimidine-carboxylate derivatives MVA P.Shanmugasundram, Mohanrangan J, Kamal Raj R Rasayan Journal of Chemistry 2 (2), 345-349, 2009 | 21* | 2009 |
| Synthesis and in vitro antioxidant activity of substituted pyridinyl 1, 3, 4 oxadiazole derivatives MV Aanandhi, MH Mansoori, S Shanmugapriya, S George, ... Res J Pharm Biol Chem Sci 1 (4), 1083-1090, 2010 | 19 | 2010 |
| VALERIANA JATAMANSI: AN ETHNOBOTANICAL REVIEW A PATAN, K ALEKHYA, V AANANDHI, K THARAGESH, A ANISH Asian J Pharm Clin Res 11 (Special issue 4), 38-40, 2018 | 18 | 2018 |
| Synthesis, Characterization and Invitro Anti Inflammatory and Anthelmintic Activities Of 1, 3, 4-Oxadiazole Derivatives. VAM Bharathi, D International Journal of ChemTech Research 2 (4), 1867-1870, 2010 | 18 | 2010 |
| Molecular docking studies on naturally occurring selected flavones against protease enzyme of Dengue virus. S Vijey Aanandhi.M, V Ravichandiran Research Journal of Pharmacy and Technology 9 (7), 929-932, 2016 | 16* | 2016 |
| Novel reverse phase HPLC method development and validation of Fluconazole and Tinidazole in a combined tablet dosage form. B Chiranjeevi, P Shanmugasundaram, MV Aanandhi International Journal of ChemTech Research 3 (3), 1309-1317, 2011 | 15 | 2011 |
| Simultaneous estimation of domperidone and lansoprazole in capsule formulation by HPTLC method MV Aanandhi, N Thiyagarajan, M Koilraj, P Shanmugasundaram, ... Rasayan Journal of Chemistry 1, 15-17, 2009 | 15 | 2009 |
| Impact of patient counselling on the knowledge, attitude, practice and quality of life in patients with hypertension with diabetes mellitus-II RC Puvvada, VA Muthukumar Indian Journal of Pharmaceutical Education and Research 52 (2), 305 - 310, 2018 | 14 | 2018 |
| Application of 3d qsar and docking studies in optimization of perylene diimides as anti cancer agent CN Hemalatha, VA Muthkumar Indian J. Pharm. Educ. Res 52 (4), 666-675, 2018 | 13 | 2018 |
| Design, Synthesis and In Silico Molecular Docking Study of N-carbamoyl-6-oxo-1-phenyl-1, 6-dihydropyridine-3-carboxamide derivatives as Fibroblast growth factor 1 inhibitor PS Misra, V Ravichandiran, MV Aanandhi Research J. Pharm. and Tech. 10 (8), 2527-2534, 2017 | 13 | 2017 |
Praveen.DSt.Peter's Institute of Pharmaceutical Sciences在 stpeters.in 的电子邮件经过验证
